EICHOR
● Completed
A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
Condition: Plasma Cell Myeloma · Sponsor: Sanofi
About this study
Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to first subsequent therapy, rate of very good partial response or better, rate of complete response (CR) or better of isatuximab patients with RRMM in routine clinical practice To assess the profile of patients (demographic, disease characteristics, comorbidities and prior MM treatment history) who are treated with isatuximab in routine clinical practice To describe safety of isatuximab in routine clinical practice (based on adverse event \[AE\] reporting) To assess quality of life (QoL) using the European Organization for Research and Treatment of Cancer (EORTC) 30 item core questionnaire (QLQ C30) and the accompanying 20 item myeloma questionnaire module (QLQ MY20) Secondary Objective: Not applicable
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (129)
| University of Arkansas Medical Sciences Site Number : 8400021 | Little Rock, Arkansas, United States | — |
| St. Joseph Heritage Healthcare Site Number : 8400008 | Fullerton, California, United States | — |
| University of California San Francisco (PARENT) Site Number : 8400009 | San Francisco, California, United States | — |
| Holy Cross Hospital Site Number : 8400030 | Fort Lauderdale, Florida, United States | — |
| GenesisCare Site Number : 8400007 | Jacksonville, Florida, United States | — |
| Watson Clinic Cancer and Research Center Site Number : 8400023 | Lakeland, Florida, United States | — |
| Millennium Oncology Site Number : 8400025 | Pembroke Pines, Florida, United States | — |
| Comprehensive Hematology Oncology Site Number : 8400026 | St. Petersburg, Florida, United States | — |
| Central Care Cancer Center Site Number : 8400019 | Garden City, Kansas, United States | — |
| Central Maine Medical Center Site Number : 8400031 | Lewiston, Maine, United States | — |
| Michigan Center of Medical Research Site Number : 8400010 | Farmington Hills, Michigan, United States | — |
| Central Care Cancer Center Site Number : 8400006 | Garden City, Missouri, United States | — |
+ 117 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04458831